Lithium tris[μ3-[3-(hydroxy-κO)-4-[(4-methyl-1-piperazinyl)methyl]-2(1H)-pyridinonato(2-)-κN1:κO2:κO2]]tris[[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]ruthenium] CAS 835614-74-9

Purity 97%+In StockPharmaceutical Standards
CAS No.835614-74-9
Molecular Formula-
Molecular WeightN/A
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

Lithium tris[μ3-[3-(hydroxy-κO)-4-[(4-methyl-1-piperazinyl)methyl]-2(1H)-pyridinonato(2-)-κN1:κO2:κO2]]tris[[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]ruthenium] CAS 835614-74-9 chemical structure

Description

CATO supplies Lithium tris[μ3-[3-(hydroxy-κO)-4-[(4-methyl-1-piperazinyl)methyl]-2(1H)-pyridinonato(2-)-κN1:κO2:κO2]]tris[[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]ruthenium] (CAS 835614-74-9), a pharmaceutical standards reference standard manufactured under ISO 17034 accreditation. Batch-specific COA and technical support are available on request.

Physical & Chemical Properties

Purity97%+
StorageStore at 2-8°C
Solubility (reference)Freely soluble in water
StabilityStable under recommended storage conditions
CAS Registry Year (est.)1986

Related Lithium Standards

Recommended Standards

Why CATO?